IRIS Institutional Research Information System - OPENBS Open Archive UniBS

DELL'ERA, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.615
EU - Europa 3.966
AS - Asia 3.723
SA - Sud America 510
AF - Africa 87
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.940
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.504
CN - Cina 1.363
PL - Polonia 1.348
SG - Singapore 1.221
UA - Ucraina 644
DE - Germania 459
BR - Brasile 421
HK - Hong Kong 383
IT - Italia 380
FI - Finlandia 244
GB - Regno Unito 235
VN - Vietnam 215
FR - Francia 200
IN - India 135
RU - Federazione Russa 130
TR - Turchia 119
IE - Irlanda 108
BD - Bangladesh 75
CA - Canada 59
ES - Italia 42
NL - Olanda 39
AR - Argentina 37
ID - Indonesia 34
CZ - Repubblica Ceca 33
MX - Messico 32
JP - Giappone 30
SE - Svezia 30
ZA - Sudafrica 28
AU - Australia 27
BE - Belgio 25
IQ - Iraq 20
EC - Ecuador 14
SA - Arabia Saudita 14
PK - Pakistan 13
CO - Colombia 12
MA - Marocco 12
NG - Nigeria 11
TW - Taiwan 11
UZ - Uzbekistan 11
VE - Venezuela 11
AT - Austria 10
EU - Europa 9
IR - Iran 9
CH - Svizzera 8
DZ - Algeria 8
KR - Corea 8
MY - Malesia 8
AZ - Azerbaigian 7
IL - Israele 6
KE - Kenya 6
KZ - Kazakistan 6
LT - Lituania 6
JM - Giamaica 5
JO - Giordania 5
KG - Kirghizistan 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
EG - Egitto 4
PY - Paraguay 4
BG - Bulgaria 3
CL - Cile 3
GR - Grecia 3
MD - Moldavia 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
SD - Sudan 3
TH - Thailandia 3
TN - Tunisia 3
AO - Angola 2
CI - Costa d'Avorio 2
HN - Honduras 2
HU - Ungheria 2
LB - Libano 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FJ - Figi 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
Totale 16.926
Salva come PNG Salva come JPEG
Città #
Warsaw 1.343
Fairfield 1.025
Woodbridge 797
Ashburn 785
Singapore 644
Houston 501
Jacksonville 475
Cambridge 412
Seattle 400
Ann Arbor 394
Hong Kong 372
Wilmington 369
San Jose 329
Chandler 289
Beijing 259
The Dalles 240
Princeton 201
Nanjing 173
Helsinki 152
New York 147
Los Angeles 125
Dublin 107
Brescia 102
Chicago 95
Dallas 95
Dearborn 95
Lauterbourg 90
Istanbul 87
Munich 72
Buffalo 65
Dong Ket 62
Moscow 60
Changsha 58
Ho Chi Minh City 53
Nanchang 53
San Francisco 53
Shanghai 52
Milan 48
São Paulo 47
Shenyang 43
Jinan 42
Des Moines 39
Council Bluffs 38
San Diego 38
Hebei 36
Orem 36
Redondo Beach 36
Lancaster 35
Tianjin 34
Santa Clara 33
Jiaxing 32
Phoenix 31
Hanoi 30
Hangzhou 29
Manchester 28
Tokyo 26
Boardman 25
Brussels 25
Chennai 25
London 25
Brooklyn 24
Jakarta 23
Kunming 22
San Mateo 21
Tampa 21
Taizhou 20
Brno 19
Salt Lake City 19
Amsterdam 18
Denver 18
Montreal 18
Ningbo 18
Atlanta 17
Guangzhou 17
Lanzhou 17
Stockholm 16
Augusta 15
Elk Grove Village 15
Leawood 15
Mumbai 15
Vieste 15
Olomouc 14
Belo Horizonte 13
Haikou 13
Poplar 13
Toronto 13
Turku 13
Zhengzhou 13
Boston 12
Brasília 12
Frankfurt am Main 12
New Delhi 12
Rome 12
Seveso 12
Abuja 11
Barcelona 11
Fuzhou 11
Mexico City 11
Verona 11
Ankara 10
Totale 12.024
Salva come PNG Salva come JPEG
Nome #
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 383
Comparative analysis of mesenchymal stromal cells biological properties 355
Clinical potentials of human pluripotent stem cells 329
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a KCNA5 p.D322H mutation 327
Generation and characterization of human cardiomyocytes derived from pluripotent stem cells 319
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 314
Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation 306
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 299
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation 295
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 289
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 269
Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System 266
Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells 246
Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM 240
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 221
NOVEL GELATIN-BASED HYDROGELS FOR TISSUE ENGINEERING APPLICATION 216
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 214
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 212
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 207
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 207
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 206
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 205
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 196
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 191
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 191
Preliminary Study of Inkjet Printed Sensors for Monitoring Cell Cultures 190
MEMS force microactuator with displacement sensing for mechanobiology experiments 189
Carbon on poly(ε-caprolactone) (PCL) ink-jet printed sensor for monitoring cell cultures of myoblasts 189
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 188
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 188
Preparation and properties of high performance gelatin-based hydrogels with chitosan or hydroxyethyl cellulose for tissue engineering applications 187
Biomanufacturing of a Chitosan/Collagen Scaffold to Drive Adhesion and Alignment of Human Cardiomyocyte Derived from Stem Cells 186
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 181
Preparation and assessment of high performance gelatin-based hydrogels for tissue engineering 179
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 177
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 177
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 174
Ink-jet printed stretchable sensors for cell monitoring under mechanical stimuli: A feasibility study 171
Generazione di cardiomiociti umani per lo studio di patologie cardiovascolari 169
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 166
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 166
Increased frequency rate and alteration of If current in iPSC-derived atrial fibrillation human cardiomyocytes. 163
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 160
iPS, organoids and 3D models as advanced tools for in vitro toxicology 158
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 157
ELM: a new, simple, and economic assay to measure motility of lymphatic endothelial cells 156
Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. 155
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 155
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. 155
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises 151
Prediction of abdominal aortic aneurysm calcification by means of variation of high-sensitivity C-reactive protein 151
Arrangement of live human cells through acoustic waves generated by piezoelectric actuators for tissue engineering applications 151
Microstructured scaffold for guided cellular orientation: Poly(ε-caprolactone) electrospinning on laser ablated titanium collector 150
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 148
Using iPS cells toward the understanding of parkinson'€™s disease 145
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 145
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 144
Fibroblast growth factor-2 in angiogenesis 143
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 143
FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. 143
iPS technology as a tool to investigate atrial fibrillation. 142
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. 140
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 140
iPSC-derived human cardiomyocytes from atrial fibrillation patients show increased frequency rate and alteration of If current 137
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle. 136
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 135
Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. 134
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 134
Microsample stiffness MEMS sensor for on-chip mechanobiology experiments 134
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 133
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 133
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 133
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 131
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 131
Atrial fibrillation modeling with iPSC derived cardiomyocyte 131
Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. 128
Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. 126
Patient-derived IPSC as a tool to unravel molecular determinants of familial atrial fibrillation 125
Differential expression of fibroblast growth factor receptors by human neurones, astrocytes and microglia. 124
Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. 123
Preliminary report: hiPSC reprogramming and karyotypic studies 122
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 121
Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy youngadults. 121
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 120
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 113
hiPSC reprogramming and karyotypic alterations: a brief report 113
iPS technology as a tool to investigate atrial fibrillation 112
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 110
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 110
Functional and biochemical characterization of induced Pluripotent Stem cells (iPSCs) from patients with Neutral Lipid Storage Disease with Myopathy 109
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 106
A detailed characterization of the hyperpolarization-activated “funny” current (If) in human-induced pluripotent stem cell (iPSC)–derived cardiomyocytes with pacemaker activity 106
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 103
Placental pericytes: the initial characterization shows similarities, as well as peculiar differences, with mesenchymal stem/stromal cells. 101
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. 100
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 99
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration 96
Generation of the induced pluripotent stem cell line UNIBSi017-A from an individual with cardiospondylocarpofacial syndrome and the MAP3K7 c.737-7A > G variant. 81
Characterization of subcutaneous and visceral fat derived mesenchymal stromal cells 81
Fat-derived mesenchymal stromal cells: different sources, different properties 80
Totale 17.007
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.685
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021121 0 0 0 0 0 0 0 0 0 0 0 121
2021/2022941 61 201 16 17 10 56 51 57 41 133 72 226
2022/2023836 112 28 26 54 73 210 1 113 139 13 35 32
2023/2024838 57 21 95 42 43 111 32 38 205 19 27 148
2024/20252.047 26 19 5 280 180 185 158 48 266 132 521 227
2025/20264.101 394 471 303 519 545 305 637 130 291 330 144 32
Totale 17.194